Empirical Evidence Synthesis
Primary Care SBIRT Outcomes & Cost-Benefit Evidence
Peer-reviewed evaluations of Wisconsin primary care clinics, national residency cohorts, and employer-inclusive health economics demonstrate durable reductions in binge drinking and acute utilization.
Primary citations: Quanbeck et al., 2010 (PMC2957302), Pringle et al., 2012 (PMC3312535), and Paltzer et al., 2017 (PMC6590672).
1. Peer-Reviewed Program & Trial Benchmarks
| Study / Source | Setting & Cohort | Measured Endpoint | Observed Outcome |
|---|---|---|---|
| Quanbeck et al., 2010 (NIH PubMed Central Benefit-Cost Evaluation) | Wisconsin SBIRT Clinics + Employer Perspective | Program cost vs. medical, crash & employer savings | Positive net societal benefit-cost ratio when downstream trauma/ED offsets are counted |
| Pringle et al., 2012 (JGME National Residency Trial) | National SBIRT Residency Training Project (JGME) | Nearly 3,000 trained residents across specialties | Sustained increases in resident confidence, brief intervention delivery, and coding fluency |
| Paltzer et al., 2017 (Wisconsin Primary Care Cohort Study) | Wisconsin Primary Care Subgroups (paraprofessional educators) | 6-month self-reported marijuana and drug use | 15% reduction in self-reported marijuana use in subgroup; paraprofessional model feasible |
| Wisconsin Clinic Rollout (Isthmus / Careers of Substance) | ~40 general healthcare settings | >110,000 screens / >25,000 interventions | 20% decrease in binge drinking, 50% fewer motor vehicle crashes, 46% fewer alcohol arrests |
2. Downstream Utilization & Prevention Yield
3. Panel Screening & Utilization Offset Modeler
Clinic Panel Annual Yield & ED Offset Projector
800 Positive Screens4. Methodological Nuance & Evidence Boundaries
USPSTF and subsequent pragmatic trials emphasize an important clinical distinction: brief primary care interventions demonstrate strongest efficacy for non-dependent hazardous alcohol use. Patients meeting criteria for severe alcohol use disorder or opioid/stimulant dependence require structured multi-session therapy, same-day warm handoffs, and FDA-approved pharmacotherapy rather than single-encounter counseling alone.
Similarly, Paltzer et al. (2017) documented meaningful 6-month reductions in marijuana use among specific paraprofessional-counseled subgroups while noting null effects for non-cannabis illicit drugs without specialty linkage, underscoring why primary care clinics pair SBIRT with accessible outpatient MOUD and behavioral health teams.